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Fragile X syndrome, a common form of inherited
intellectual disability, is caused by loss of the fragile
X mental retardation protein FMRP. FMRP is present
predominantly in the cytoplasm, where it regulates
translation of proteins that are important for synaptic
function. We identify FMRP as a chromatin-binding
protein that functions in the DNA damage response
(DDR). Specifically, we show that FMRP binds chro-
matin through its tandem Tudor (Agenet) domain
in vitro and associates with chromatin in vivo. We
also demonstrate that FMRP participates in the
DDR in a chromatin-binding-dependent manner.
The DDR machinery is known to play important roles
in developmental processes such as gametogenesis.
We show that FMRP occupiesmeiotic chromosomes
and regulates the dynamics of the DDR machinery
during mouse spermatogenesis. These findings sug-
gest that nuclear FMRP regulates genomic stability
at the chromatin interface and may impact gameto-
genesis and some developmental aspects of fragile
X syndrome.
INTRODUCTION
Chromatin is a complex biological entity comprised of DNA
wrapped around histone octamers (Wolffe and Guschin, 2000).Posttranslational modifications of histone proteins serve as an
interface for various chromatin ‘‘readers,’’ which are chro-
matin-binding proteins that coordinate downstream processes,
including the DNA damage response (DDR) and repair events
(Costelloe et al., 2006; Downs et al., 2007; Stucki and Jackson,
2006). Themammalian DDR pathway is initiated by the activation
of several conserved protein kinases, including ATM and ATR,
which are members of the phosphatidylinositol 3-kinase-related
kinase (PIKK) family. While ATM is activated by DNA double-
strand breaks (DSBs), ATR activity is triggered by stalled replica-
tion forks as well as single-strand DNA (Ciccia and Elledge,
2010). Upon activation, ATR phosphorylates histone H2A.X at
serine 139 (termed gH2A.X) (Ciccia and Elledge, 2010; Liu
et al., 2006; Ward and Chen, 2001) and the breast cancer-asso-
ciated tumor-suppressor protein BRCA1 at serine 1423 (Gatei
et al., 2001; Tibbetts et al., 2000). Both gH2A.X and BRCA1
are important regulators of genomic stability (Celeste et al.,
2002; Nagaraju and Scully, 2007).
The fragile X mental retardation protein FMRP is an RNA-
binding protein that functions mainly at the neuronal dendrites,
where it associates with specific mRNAs and modulates their
translation, thus regulating a subset of proteins involved in syn-
aptic function (Bassell and Warren, 2008; Brown et al., 2001).
FMRP is critical for metabotropic glutamate receptor (mGluR)-
dependent long-term depression, as well as other forms of
synaptic plasticity. The lack of FMRP due to FMR1 gene
silencing results in fragile X syndrome, a common form of in-
herited intellectual disability and one of the leading causes of
autism (Bear et al., 2004; Garber et al., 2008; Nelson, 1995;
O’Donnell and Warren, 2002; Santoro et al., 2012; Warren andCell 157, 869–881, May 8, 2014 ª2014 Elsevier Inc. 869
Figure 1. FMRP Modulates Histone H2A.X
Phosphorylation Levels in Response to
Replication Stress
(A) Wild-type (WT), but not FMRP KO, MEFs
exhibited dose-dependent gH2A.X induction in
response to APH (lanes 1–4). See also Figures S1A–
S1C.
(B) WT MEFs and FMRP KOMEFs exhibited similar
degrees of gH2A.X induction (5-fold) in response to
5 Gy of irradiation (lanes 1 and 2).
(C) WT, but not FMRP KO, MEFs exhibited time-
dependent gH2A.X induction in response to 50
J/m2 of UV irradiation or 2 mM of HU (10-fold in-
duction at 60 min posttreatment; compare lanes 1–
4 with lanes 5–8).
(D) FMRPKOMEFs reconstitutedwithWT Flag-HA-
FMRP (pMSCV-Flag-HA-FMRP) or vector alone
(pMSCV-Flag-HA) were exposed to various con-
centrations of APH. See also Figure S1D. pMSCV-
Flag-HA-FMRP MEFs exhibited more pronounced
gH2A.X induction compared with pMSCV-Flag-HA
cells (12-fold in Flag-HA-FMRP cells and 4-fold in
Flag-HA cells; lanes 1–4).
(E) FMRP RNAi HeLa cells, but not control cells,
showed diminished gH2A.X induction in response
to APH (3.4-fold and 8-fold, respectively; compare
lanes 1/2 with 3/4, and 5/6 with 7/8). See also Fig-
ures S1E, S1F, and S2.Nelson, 1994). Besides cognitive impairment, fragile X males
also display macroorchidism (Johannisson et al., 1987; O’Don-
nell and Warren, 2002) and female Fmr1 KO mice develop
abnormal ovaries (Ascano et al., 2012), indicating an additional
germline or gonadal effect of disruption of Fmr1 expression.
Previous studies demonstrated a wide tissue distribution for
FMRP and established it as largely a cytoplasmic protein, with
only about 4% FMRP in the nucleus (Feng et al., 1997), where
its function remains unknown. However, several reports sug-
gested a potential role for FMRP in the nucleus. Studies in
Xenopus and zebrafish showed that at 2–3 hr postfertilization,
Fmrp is predominantly nuclear (Blonden et al., 2005; Kim et al.,
2009; van ’t Padje et al., 2005). In addition, Fmrp was found to
decorate lampbrush chromosomes in Xenopus oocytes (Kim
et al., 2009). Furthermore, nuclear FMRP interacting protein
(NUFIP) associates with BRCA1 (Cabart et al., 2004), suggesting
a potential functional relationship between FMRP and BRCA1 in
the nucleus. FMRP has also been found in the PARP complexes,
which heavily influence the DDR cascades (Helleday et al., 2005;
Isabelle et al., 2010; Kedar et al., 2008). Interestingly, mice lack-
ing the DNA topoisomerase TOP3b, which is part of FMRP-
containing messenger ribonucleoprotein particles (mRNPs) and
is implicated in neuronal development, display progressive
reduction in fecundity and aneuploidy (Kwan et al., 2003; Stoll
et al., 2013). The fact that FMRP is present in DDR complexes
and is predominantly nuclear in some gametes and early em-
bryos led us to speculate that FMRP might have a novel nuclear
function in the DDR during development.
In this study, we provide evidence that FMRP has an important
role in the nucleus, where it modulates the replication stress
response at the chromatin interface. We show that FMRP
regulates H2A.X phosphorylation, BRCA1 focus formation, and870 Cell 157, 869–881, May 8, 2014 ª2014 Elsevier Inc.accumulation of single-strand DNA intermediates in a chromatin
binding-dependent manner, and this nuclear role of FMRP is
separable from its well-established role in translational regula-
tion. We extend this nuclear function of FMRP to mammalian
meiosis using mouse spermatocytes as a model. We show that
FMRP decorates meiotic chromosomes and regulates gH2A.X
induction, BRCA1 and ATR recruitment, and resolution of sin-
gle-strand repair intermediates during meiosis. Taken together,
our findings identify FMRP as a chromatin-binding protein and
demonstrate that it plays a previously unanticipated role in the
DDR at the chromatin interface, which is independent from the
canonical role of FMRP in translational regulation.
RESULTS
Loss of FMRP Compromises Phosphorylation of H2A.X
in Response to Replication Stress
In order to determine whether FMRP has a role in the DDR, we
analyzed gH2A.X induction in cells that lack FMRP. We first
treated wild-type and FMRP knockout (KO) mouse embryonic
fibroblasts (MEFs) with increasing concentrations of the replica-
tion stress inducer aphidicolin (APH), which largely triggers
single-strand breaks, and ionizing radiation, which generates
DSBs (Brown and Baltimore, 2003; Rogakou et al., 1998; Zhou
and Elledge, 2000). In wild-type but not FMRP KO, MEFs,
APH-induced replication stress elicited an 20-fold induction
of gH2A.X (Figure 1A, compare lanes 1–4 of the first and third
panels), indicating a requirement for FMRP in the replication
stress response. In addition, FMRP KO MEFs showed reduced
formation of gH2A.X foci upon treatment with APH as compared
to wild-type MEFs (Figures S1A–S1C available online). In
contrast, FMRP KO cells showed gH2A.X induction comparable
Figure 2. FMRP Chromatin Recruitment in
Response to Replication Stress
(A) MEFs were treated with DMSO (lane 1) or APH
(lane 2). Chromatin fractions were isolated and
western blotted for FMRP. Bar graph, relative ratio
of chromatin-associated FMRP to total FMRP.
*p < 0.05, Student’s t test. Data are an average of
three independent experiments with SD.
(B) Immunostaining of nuclear FMRP in APH-
treated or DMSO-treated MEFs in the presence of
LPB. a: FMRP colocalized with CENT B next to
CMCs. Arrowheads, representative colocalized
FMRP (red) and CENT B (green) foci docked near
CMCs. b: Representative FMRP signal (Ab-1: anti-
FMRP [Abcam] antibody [red], Ab-2: anti-FMRP
[Calbiotech] antibody [green]) enveloping CMCs in
LPB-treated MEFs. c: Representative FMRP foci
in LPB+APH-treated cells. d: representative
FMRP signals enveloping CMCs in LPB+APH-
treated MEFs. Arrowheads, selected FMRP foci
wrapped around CMCs. Scale bar, 10 mm.
(C) APH treatment resulted in doubling of the
number of cells with five or more FMRP foci (>5) or
FMRP CMCs. *p < 0.05, Student’s t test. Data are
an average of three independent experiments with
SD. See also Figure S3.to that of the wild-type MEFs in response to ionizing radiation,
indicating an intact response to DSB (Figure 1B, lane 2). In
sum, FMRP KO MEFs showed distinct responses to different
types of DNA damage, i.e., they responded to DSBs similarly
to wild-type MEFs, but were defective in their response to repli-
cation stress.
To confirm that FMRPKOMEFs are defective in their response
to replication stress, we subjected FMRP KOMEFs to additional
sources of replication stress agents, including hydroxyurea (HU)
and UV irradiation. In both cases, FMRP KOMEFs failed to show
a time-dependent increase of the gH2A.X level as compared to
wild-type MEFs (10-fold induction at 60 min posttreatment; Fig-
ure 1C, compare lanes 1–4 with lanes 5–8 of the upper and lower
panels). Importantly, FMRPKOMEFs reconstitutedwith a FLAG-
HA epitope-tagged, wild-type FMRP (Flag-HA-FMRP) conferred
a more robust gH2A.X response to increasing concentrations of
APH compared with the Flag-HA vector alone (Figures 1D and
S1D; 12-fold induction in Flag-HA-FMRP cells as compared to
4-fold induction in Flag-HA only cells). This was not a MEF-
cell-specific effect, since reduction of FMRP in HeLa cells by
RNAi also resulted in a compromised induction of gH2AX in
response to replication stress (Figure 1E). In addition to H2A.X
phosphorylation regulation, loss of FMRP also affected anotherCell 157, 869ATR-dependent, replication response-
specific phosphorylation event: phos-
phorylation of BRCA1 at Ser-1423
(Tibbetts et al., 2000; Figures S1E and
S1F). Consistent with the potential role
of FMRP in the replication stress
response, FMRP RNAi knockdown HeLa
cells reconstituted with Flag-HA vector
alone, but not tagged wild-type FMRP(Flag-HA-FMRP), were more sensitive to replication stress in
the clonogenic survival assay (Figures S2A and S2B), and
FMRP KO MEFs were also more sensitive to replication stress
compared to wild-type MEFs (Figure S2C). These findings are
in line with previous reports describing a prosurvival role of
FMRP (Jeon et al., 2011, 2012; Liu et al., 2012). Taken together,
the above findings link FMRP to replication stress-induced DDR
and indicate that FMRP may be part of the ATR-dependent
signaling pathway.
FMRP Is Recruited to Chromatin in Response to
Replication Stress
Many proteins that function in the DDR are recruited to chro-
matin in response to DNA damage, where they participate in
the DDR events (Bostelman et al., 2007; Conde et al., 2009;
Krum et al., 2010; Pei et al., 2011; Wakeman et al., 2012;
Wysocki et al., 2005). We therefore investigated the possibility
that the FMRP may function in the replication stress response
through recruitment to chromatin. By chromatin fractionation,
we detected association of FMRPwith chromatin, and this asso-
ciation was elevated by 4-fold upon APH treatment (Figure 2A,
compare lanes 1 and 2). Although biochemical fractionation
allows detection of FMRP association with chromatin, direct–881, May 8, 2014 ª2014 Elsevier Inc. 871
Figure 3. FMRP Docking to Chromatin Is
Essential for FMRP-Dependent Modulation
of gH2A.X Levels in Response to Replica-
tion Stress
(A) Diagram of AgenetFMRP. Mutations T102A and
Y103L are demarcated by triangles. See also
Figure S4.
(B)GST-FMRPorGST-FMRPcarryingmutations in
AgenetFMRP (GST-T102A and GST-Y103L) were
incubated with isolated nucleosomes. Pull-down
material was run on gradient gels followed by silver
staining. A complete set of core nucleosomal his-
tones, including H3, H2A, H2B, and H4, were de-
tected inWT,but notmutant, FMRP-mediatedpull-
downs (compare lanes 3–5). See also Figure S5A.
(C) WT FMRP (lanes 1 and 2) triggered more
pronounced gH2A.X induction in FMRP KO MEFs
in response to APH (12.8-fold) as compared with
FMRP mutants (4-fold and 3-fold gH2A.X for
Y103L and T102A mutants respectively; lanes
3–6). See also Figure S1D.
(D) FMRP RNAi in HeLa cells abolished gH2A.X
induction in response to APH as compared with
control RNAi (compare lanes 1/2 with lanes 3/4).
Cotransfection with constructs expressing WT but
not mutant forms of FMRP restored the induction
of gH2A.X in FMRP RNAi cells in response to APH
(compare lanes 5/6 with lanes 7/8 and 9/10). The
slower-migrating band (in lanes 5–10) is Flag-HA-
FMRP (indicated by an arrowhead).visualization of FMRP in the nucleus is problematic due to the
low level of nuclear FMRP (Figure S3A). However, it is possible
to raise nuclear FMRP levels by using leptomycin B (LPB), which
inhibits nuclear protein export (Tamanini et al., 1999). As shown
in Figure 2B, in the presence of LPB, we detected FMRP foci in
the vicinity of pericentromeric domains (chromocenters [CMCs]),
which are easily recognizable in the mouse nuclei as large DAPI-
positive domains (Figure 2B, a and b). Consistently, FMRP stain-
ing overlapped with the centromeric protein B (CENT B) signal,
which marks pericentromeric heterochromatin (Figure 2B, a,
arrowheads). In some cases, FMRP formed larger structures
wrapped around the CMCs (Figure 2B, b, arrowheads). The
number of cells with FMRP foci as well as CMC-associated
FMRP domains increased 2-fold after APH treatment (Figures
2B, c and d, and 2C). In addition, we observed colocalization
of FMRP and gH2A.X in MEFs treated with LPB (Figures S3B
and S3C). Although the significance of FMRP colocalization
with CENT B, CMCs, and gH2A.X foci requires further investiga-
tion, the above data nevertheless indicate that FMRP accumu-
lates at specific chromatin domains and this accumulation can
be increased upon replication stress, supporting our biochem-
ical data (Figure 2A).
FMRP Binds Chromatin via Its N-Terminal Agenet
Domain, and This Interaction Is Critical for FMRP
Function in the DDR
What is the molecular basis for the observed chromatin associ-
ation of FMRP? FMRP contains an N-terminal Agenet domain
(AgenetFMRP), which is a double-tudor domain that belongs to
the Royal family of chromatin-binding proteins (Maurer-Stroh
et al., 2003; Ramos et al., 2006). Interestingly, the Agenet domain872 Cell 157, 869–881, May 8, 2014 ª2014 Elsevier Inc.was recently shown to bind histone substrates methylated at
various lysine residues (Adams-Cioaba et al., 2010; Sabra
et al., 2013). This led us to hypothesize that FMRP might target
chromatin through its Agenet domain. AgenetFMRP consists of
two adjacent Tudor domains, termed N-terminal domain of
FMRP1 (NDF1) and N-terminal domain of FMRP2 (NDF2)
(Ramos et al., 2006; Figure 3A). NMR studies identified residues
T102 and Y103 on the surface of NDF2 as important for binding
trimethylated lysine (Ramos et al., 2006; Figure 3A). Mutating
T102 and Y103 to A and L, respectively (T102A and Y103L),
significantly compromised FMRP binding to native nucleosomes
isolated from HeLa cells (Figure 3B, compare lane 3 with lanes 4
and 5), indicating that AgenetFMRP is required for FMRP associ-
ation with nucleosomal substrates. We next explored the possi-
bility that methyl-lysine recognition is involved in FMRP binding
to chromatin. We used a panel of recombinant Xenopus histones
carrying methyl-lysine analogs at various positions (Simon et al.,
2007) in in vitro binding reactions with AgenetFMRP. AgenetFMRP
did not show a significant interaction with unmethylated histone
H3, but bound histone H3 containing methyl-lysine analogs at
several positions (Figure S4A). Full-length FMRP also bound
methylated, but not unmethylated, histone H3 (data not shown).
We next carried out microscale thermophoresis (MST) (Jera-
bek-Willemsen et al., 2011; Wienken et al., 2010) in order to
understand the dynamics of AgenetFMRP binding to various
histone methylation marks. Consistent with the biochemical
binding data, we found that AgenetFMRP exhibited higher affinity
for histone H3 carrying lysine methylation mimics, including
H3Kc79me2 (Kd 135 ± 28 nM; Figure S4B) and H3Kc27me1
(Kd 102 ± 11 nM; Figure S4C) as compared with unmethylated
H3 (Kd 1063 ± 136 nM; Figure S4D). Both the biochemical and
MST data suggest that AgenetFMRP preferentially binds methyl-
ated histone H3, but does not display significant methyl site
specificity in vitro. Importantly, AgenetFMRP mutations that
abolish FMRP binding to native chromatin (Figures 3A and 3B)
also interfered with AgenetKHKHFMRP (Agenet and two adjacent
nucleic acid binding domains) binding to the in vitro assembled
methylated MLA nucleosomes (H3Kc79me2; Figure S5A,
compare lanes 3–5). Collectively, these data demonstrate that
AgenetFMRP is necessary and sufficient for FMRP binding to
chromatin, which might involve a sequence-independent
methyl-lysine recognition function of AgenetFMRP.
FMRP Binding to Chromatin Is Required for FMRP-
Dependent Modulation of gH2A.X Levels in Response to
Replication Stress
We next carried out genetic complementation experiments to
investigate potential functional roles of FMRP chromatin associ-
ation in the DDR. FMRP KO MEFs were reconstituted with wild-
type or mutant forms of FMRP (T102A and Y103L), which are
compromised in their ability to bind nucleosomes. Wild-type
FMRP (Figure 3C, lanes 1 and 2) was more effective than the
mutant forms of FMRP (Figures 3C, lanes 3–6, and S1D, which
shows comparable expression of wild-type and mutant FMRP
proteins) in conferring the induction of H2A.X phosphorylation
in the mouse FMRP KO MEF cells in response to APH treatment
(12.8-fold gH2A.X increase with the wild-type FMRP and 4- and
3-fold gH2A.X increase with the Y103L and T102A mutants,
respectively). Similar results were obtained with HeLa cells in
which the endogenous FMRP was inhibited by RNAi, and which
were then complemented with either the wild-type FMRP or the
FMRPAgenet domainmutants. As shown in Figure 3D, wild-type
FMRP conferred a significantly higher level of gH2A.X response
(9-fold induction, compare lanes 5 and 6, third panel from the
top) than the Agenet point mutants (T102A and Y103L; 3-fold
gH2A.X induction, compare lanes 7 and 8, and lanes 9 and 10,
third panel from the top). These findings suggest that the recruit-
ment of FMRP to chromatin is critical for FMRP-dependent regu-
lation of H2A.X phosphorylation.
FMRP Mutants Defective in Supporting H2A.X
PhosphorylationAreNotCompromised in Their Ability to
Modulate Translation-Dependent AMPAR Trafficking
FMRP has a well-documented role in regulating activity-depen-
dent synaptic translation of a specific subset of mRNAs, which is
important for the maintenance of synaptic plasticity (Bassell and
Warren, 2008; Bear et al., 2004; Brown et al., 2001; O’Donnell
and Warren, 2002). Previous studies showed that a reduction
of FMRP in dendrites leads to an excessive internalization
of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic
acid receptor (AMPAR) subunit GluR1 (Nakamoto et al., 2007),
which is a critical process for the maintenance of synaptic plas-
ticity. This finding provided the foundation for the mGluR theory
of fragile X syndrome (Bear et al., 2004). We asked whether the
chromatin-binding-defective FMRP point mutants were also
compromised in their ability to dampen AMPAR internalization.
As expected, immunofluorescence staining showed that FMRP
KO neurons exhibited less AMPAR signal remaining on the sur-
face and more internalized AMPAR signal relative to wild-typeneurons (Figure S5B, compare panels 1 and 2). Quantitatively,
the ratio of internalized to total AMPARs was increased in neu-
rons isolated from Fmr1 KO mice as compared with wild-type
neurons (Figure S5C, compare boxplots 1 and 2). Importantly,
the FMRP chromatin-binding-defective mutants were able to
rescue this AMPAR trafficking defect similarly to the wild-type
FMRP (Figures S5B, panels 3–5, and S5C [compare boxplot 1
with boxplots 2 and 3–5]). These findings indicate that the newly
identified role of FMRP in the DDR is mechanistically distinct
from its canonical function in modulating synaptic strength.
FMRP Patient Mutant R138Q Is Defective in Mediating
DDREvents, but Retains Normal Translation-Dependent
AMPAR Internalization
Recently, a novel FMRPsequence variant, R138Q,was found in a
developmentally delayed male without the typical CGG-repeat
expansion in the 50 UTR of the FMR1 gene (Collins et al., 2010).
Because the R138Q mutation lies near the extreme C terminus
of AgenetFMRP (Figure S6A), we investigated whether this patient
mutation affects FMRP nucleosomal binding. As shown in Fig-
ure 4A, the FMRP R138Q mutant failed to bind native nucleo-
somes (compare lanes 3 and 4) as well as recombinant
H3Kc79me2 nucleosome (Figures 4B, S5A [lane 6], and S6B,
which shows comparable levels of wild-type and R138Q recom-
binant proteins used for the binding assays). Importantly, the
R138Q mutant also failed to confer gH2A.X induction in the
FMRP KO MEFs in response to replication stress (Figures 4C
[compare lanes 1–6with lanes 7–12] andS6C,which shows com-
parable levels of expression of wild-type and R138Q reconsti-
tuted in theFMRPKOMEFcells). In addition to thegH2A.Xdefect,
theR138QFMRPmutant did not effectively support the formation
of BRCA1 foci and phosphorylation of BRCA1 at Ser-1423 in
FMRP KO MEFs in response to APH treatment as compared
with wild-type FMRP (Figures 4D–4G and S6D). In addition, we
observedan increased incidenceof single-strandDNA intermedi-
ates (as indicated by RPA32 staining) in FMRPKOMEFs rescued
with the R138Q mutant as compared with wild-type FMRP, sug-
gesting a repair defect (compare Figures 4Hand4I; quantification
in Figures 4J and 4K). Importantly, RPA32 staining associated
withCMCswasalso increased inFMRPKOMEFscomplemented
with R138Q, suggesting a possible functional significance of
FMRP targeting to CMCs in the context of the DDR (Figures 4H
and 4I, bottom, arrows). FMRP KO MEFs reconstituted with the
R138Qmutant were alsomore sensitive to increasing concentra-
tions of HU as comparedwithwild-type FMRP reconstituted cells
in the clonogenic survival assay (Figure S6E). In contrast, the
FMRP R138Q mutant functioned similarly to wild-type FMRP in
suppressing excessive AMPAR internalization in FMRP KO
neurons (Figure S6F [compare panels 3 and 4] andS6G [compare
boxplots 3 and 4]). Taken together, these results suggest the
tantalizing possibility that abrogation of this newly identified
nuclear function of FMRP in the DDR may lead to a DDR-depen-
dent clinical phenotype.
FMRP Is Loaded onto Chromosomes during Male
Meiosis and Regulates Placement of gH2AX
The above findings provide strong support for a role of FMRP
in the DDR via its association with chromatin. However, theCell 157, 869–881, May 8, 2014 ª2014 Elsevier Inc. 873
Figure 4. Patient Mutant R138Q Is Defective in gH2A.X Induction and BRCA1 Foci Formation and Promotes Excessive RPA Retention on
Chromatin
(A) Unlike WT FMRP, the R138Q FMRP mutant failed to bind nucleosomes in vitro (compare lanes 3 and 4).
(B) Equilibrium binding analysis using recombinant MLA nucleosomes dimethylated at H3K79 and WT AgenetKHKH (Kd = 59 nM) or R138QKHKH (binding not
detected). See also Figures S5A and S6B.
(C) FMRP KOMEFs rescued withWT FMRP, but not the R138Q FMRP patient mutant, exhibited a dose-dependent gH2A.X response triggered by APH (0.05 mM,
0.1 mM, 0.3 mM, 0.5 mM, 1 mM). See also Figure S6C.
(legend continued on next page)
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biological significance of this finding was unclear. In this regard,
mammalian meiosis represents perhaps the most relevant
biological process in which extensive DNA damage and recom-
binogenic events normally occur. In wild-type meiotic cells,
DSBs are generated during prophase by the topoisomerase-
like enzyme SPO11, and form sites for homologous recombina-
tion and crossing over. DSBs accumulate gH2A.X and recruit
many components of the somatic DDR machinery, including
ATR and BRCA1. Repair then occurs in a highly regulated
fashion, accompanied by pairing of homologous chromosomes
(synapsis) and recombination between homologs (Blanco-Ro-
drı´guez, 2012; Garcia-Cruz et al., 2009; Turner et al., 2004,
2005). Importantly, in addition to defects in synaptic signaling
in neurons, male fragile X patients exhibit macroorchidism and
Fmr1 KO mouse ovaries display premature follicular overdevel-
opment (Ascano et al., 2012; Turner et al., 1975, 1980). Meiotic
germ cells are therefore a relevant biological context in which
to analyze the association of FMRP with chromatin in the DDR
in vivo.
We used a mouse Fmr1 KO model to investigate whether
FMRP is associated with chromatin and the DDR during
mammalian meiosis. All mouse experiments were approved by
the animal care and use committee at the appropriate institution.
We first asked whether FMRP is present in the germ cell nucleus
during meiosis. We performed immunostaining on chromosome
spreads of adult male spermatocytes in meiotic prophase.
Strikingly, we identified distinct FMRP puncta on condensed
pachytene-stage chromosomes (Figure 5A). These puncta
were aligned along the chromosomes, as visualized by costain-
ing for the synaptonemal complex (SC) component SYCP1.
FMRP puncta were not found on the chromosomes in Fmr1
KO cells, confirming the specificity of the antibody staining (Fig-
ure S7A). We conclude that FMRP is present in the nucleus
during meiotic pachytene and is localized on or near the chro-
matin at this stage.
In wild-type meiotic cells, gH2A.X accumulates throughout
the nucleus during the leptotene and zygotene stages of
prophase concomitantly with DSB formation, but is removed
from the chromosomes as repair proceeds and is absent from
the autosomes by the pachytene stage. In males, the X and Y
chromosomes retain gH2A.X during pachytene because these
two chromosomes lack homologs and cannot fully synapse,
and repair is delayed (Handel and Schimenti, 2010). Analo-
gously, in mutants with defective repair and synapsis machinery,(D and E) BRCA1 foci formation in FMRP KO MEFs rescued with WT FMRP (D) i
rescued with the R138Q FMRP patient mutant (E). See also Figure S6D.
(F) Forty percent of FMRP KO MEFs rescued with WT FMRP exhibited >50 BRCA
the R138Q patient mutant.
(G) BRCA1 S1423 phosphorylation in FMRP KO MEFs rescued with WT FMRP
R138Q FMRP patient mutant (compare lanes 2 and 4).
(H and I) RPA32 foci formation in FMRP KOMEFs rescued with WT FMRP in resp
with the R138Q patient mutant (compare middle panels in (H) and (I). Note the a
(J and K) Quantification of total (J) and CMC-associated (K) RPA32 foci in FMRPK
The percentage of cells positive for RPA32 increased from 10% to 50% upon APH
the R138Q mutant. Note increased numbers of RPA32-positive cells in the case
(K) Seventeen percent of R138Q mutant rescue MEFs and 6% of WT FMRP rescu
*p < 0.05, Student’s t test. Data are an average of three independent experimen
See also Figure S6D.gH2A.X and other components of the DDR pathway are retained
at unrepaired regions on the autosomes (Turner et al., 2005). We
asked whether deposition of gH2A.X during meiotic prophase
was impaired in Fmr1 KO cells. Fmr1 KO spermatocytes
exhibited two distinct defects in gH2A.X accumulation: (1)
reduced deposition of gH2A.X during the leptotene stage, and
(2) inappropriate retention of gH2A.X on autosomes during
pachytene (Figure 5B). This phenotype was not the result of
delayed or impaired formation of DSBs, since there was no
difference in SPO11 staining between wild-type and KO cells
(Figure S7B). These defects were evident in only a subset of cells
(Figure 5C), perhaps explaining the preserved fertility of the Fmr1
KO males.
Fmr1 Mutant Mice Exhibit Defective Chromosome
Synapsis and Defective Resolution of Single-Strand
Intermediates during Meiotic Prophase
In wild-type meiotic cells, the RAD51 homolog DMC1 associates
with the single-strand intermediates produced during DSB repair
and facilitates invasion of the homologous chromosome, allow-
ing recombination (Pittman et al., 1998; Schwacha and Kleckner,
1997; Yoshida et al., 1998). This process occurs during the zygo-
tene stage and is largely complete by pachytene, by which time
most DMC1 has dissociated from the chromosomes. Successful
strand invasion catalyzed by DMC1 is required to proceed with
repair and crossing over, including recruitment of the MLH1/
MLH3 heterodimer during middle to late pachytene (Moens
et al., 2002; Pittman et al., 1998; Yoshida et al., 1998). To deter-
mine whether single-strand intermediates were resolved in
meiotic cells in the absence of FMRP, we costained pachytene
nuclei with DMC1 andMLH1.We found that Fmr1KOmidpachy-
tene spermatocytes inappropriately retained high levels of
DMC1 on the chromosomes (Figures 6A and 6B), associated
with reduced recruitment of MLH1 (Figures 6A, 6C, and 6D).
These findings suggest that resolution of single-strand DNA
repair intermediates is delayed in meiotic germ cells in the
absence of FMRP, resulting in impaired crossover formation.
Consistent with a failure to repair DNA breaks, we found that
BRCA1 and ATR were also inappropriately retained on the
chromosomes in pachytene spermatocytes. BRCA1 and ATR
were restricted to the unpaired X and Y chromosomes in wild-
type spermatocytes, but were present on regions of the
autosomes in Fmr1 KO spermatocytes (Figures 7A–7C).
BRCA1 and ATR staining on the sex chromosomes was alson response to APH was more pronounced as compared with FMRP KO MEFs
1 foci per cell upon APH treatment, compared with 10% in MEFs rescued with
in response to APH was more pronounced as compared with rescue with the
onse to APH was less pronounced as compared with FMRP KOMEFs rescued
ccumulation of a subset of RPA32 foci at CMCs (arrowheads, lower panels).
OMEFs rescued withWT FMRP and R138Q patient mutant in response to APH.
treatment after rescue withWT FMRP, and from 40% to 70% after rescue with
of R138Q mutant rescue MEFs even in the absence of APH treatment.
e MEFs had more than five CMC-associated RPA32 foci upon APH treatment.
ts with SD. Scale bars, 10 mm.
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Figure 5. FMRP Is Present on Meiotic Chromosomes and Regulates Placement of gH2A.X
Immunofluorescence staining was performed on spread chromosomes from adult male primary spermatocytes, and cells were imaged by deconvolution
microscopy.
(A) Pachytene stage nucleus showing FMRP puncta along the chromosomes. SYCP1 marks the full length of the autosomes during the pachytene stage. Inset
shows FMRP puncta (green) aligned along SYCP1-stained chromosomes (red). See also Figure S7A.
(B) gH2A.X and FMRP staining in WT (left) and Fmr1 KO (right) primary spermatocyte nuclei at leptotene, zygotene, pachytene, and diplotene stages of meiotic
prophase. SYCP3 accumulates on chromosomes beginning in leptotene and is present along their full length during pachytene. In Fmr1KO cells, accumulation of
gH2A.X is delayed in the leptotene stage. At the pachytene stage, gH2A.X is restricted to the sex chromosomes (arrowheads) in WT cells, but remains at some
autosomal locations in Fmr1 KO cells. Scale bars, 10 mm.
(C) Percentage of cells retaining gH2A.X outside of the sex chromosomes in WT and KO pachytene spermatocytes. **p < 0.01, Fisher’s exact test. See also
Figure S7B.discontinuous in Fmr1 KO spermatocytes, but continuous in
wild-type cells. Similar to the defects in gH2A.X deposition,
DMC1 retention, and MLH1 recruitment, these BRCA1 and
ATR localization phenotypes varied between cells: some KO
cells exhibited autosomal BRCA1 and ATR staining, whereas
others resembled wild-type cells (Figure 7C).
Because failure to resolve DSBs and to form interhomolog
crossovers is also associated with defective synapsis, we next
asked whether Fmr1 KO spermatocytes also displayed synapsis
defects. SYCP3, a lateral element of the SC, assembles on
unpaired chromosomes during early prophase, whereas
SYCP1, a central element of the SC, assembles only on syn-
apsed chromosomes (Fraune et al., 2012). We found that
whereas wild-type pachytene nuclei had continuous SYCP1876 Cell 157, 869–881, May 8, 2014 ª2014 Elsevier Inc.staining along the chromosomes, many Fmr1 KO nuclei had
discontinuous SYCP1 staining, indicating that SC formation
was not complete (Figure 7D; Bishop et al., 1992; Pittman
et al., 1998; Yoshida et al., 1998). Taken together, these findings
suggest that resolution of single-strand repair intermediates,
crossing over, and subsequent pairing of homologous chromo-
somes during meiotic prophase are incomplete in a subset of
spermatocytes lacking FMRP.
Histone H3K79 Methylation Plays a Role in the
Recruitment of FMRP to Chromatin In Vivo
As described above, both the AgenetFMRP and a full-length
FMRP bind histone substrates in a methyl-lysine-dependent
manner (Figure S4 and data not shown). However, it remains
Figure 6. Fmr1 KO Spermatocytes Exhibit
DNA Repair Defects and Delayed Resolu-
tion of Single-Strand Intermediates at the
Pachytene Stage
Staining of chromosome spreads was performed
as in Figure 5.
(A) Costaining of DMC1, MLH1, and the SC
component SYCP3, showing retention of DMC1
and reduction of MLH1 in Fmr1 KO cells at mid-
pachytene.
(B) Numbers of WT and KO cells positive for DMC1
staining at midpachytene. ***p < 0.0001, Fisher’s
exact test.
(C) MLH1 foci per midpachytene nucleus in WT
and KO. **p < 0.01, Mann-Whitney U test.
(D) Number of chromosomes per midpachytene
nucleus lacking MLH1 foci. In WT cells, there is at
least one MLH1 focus per chromosome. ***p <
0.0001, Mann-Whitney U test. Scale bars, 10 mm.unclear whether FMRP binds methyl histones with some speci-
ficity in vivo and which methyltransferases are necessary for
FMRP chromatin recruitment. Dot1, the H3K79 methyltransfer-
ase, has been shown to play a role in yeast meiosis (Ontoso
et al., 2013; San-Segundo and Roeder, 2000). In addition, recent
reports demonstrated an increase in H3K79me2 and H3K79me3
levels in mouse spermatocytes in pachytene, with H3K79me3
specifically enriched at the sex chromosomes and centromeres
(Ontoso et al., 2014). As a first step toward understanding the
role of histone methylation in FMRP recruitment, we generated
mice conditionally lacking DOT1L (Dot1L cKO; Figures S7C–
S7E; Bernt et al., 2011), the only known mammalian H3K79
methyltransferase, in the germ cells, and stained meiotic
spreads for FMRP. We found a small but significant reduction
in the number of chromatin-associated FMRP puncta in the
Dot1L cKO. This effect was especially evident on the X and Y
chromosomes, where FMRP is particularly abundant during
pachytene (Figures 7E and 7F). Importantly, similar to FMRP
KO MEFs, Dot1L mutant MEFs exhibited reduced gH2A.X foci
formation in response to APH (Figure S1C, right) as well as an
increased sensitivity to increasing concentrations of APH
compared with wild-type MEFs (Figure S2C). We conclude that
methylated H3K79 might function in the same DDR pathway as
FMRP and help to recruit or retain FMRP at chromatin associ-
ated with DNA damage repair intermediates.
DISCUSSION
We have identified FMRP as a chromatin-binding protein and
uncovered a novel and unanticipated function for FMRP in the
nucleus, where it regulates the DDR. In addition, we uncovered
a biological role for the DDR function of FMRPduringmammalian
spermatogenesis. We provide strong evidence that the Agenet
domain binds histone H3 in a methylation-dependent manner,
without displaying an overt preference toward a specificCell 157, 869methyl-lysine site. Conceivably, however,
the binding specificity could be enhanced
in vivo. Our preliminary data consistentlyshowed that the histone H3K79 methyltransferase DOT1L is
important for FMRP chromatin association during meiosis,
suggesting that H3K79 methylation may play a role in FMRP
chromatin targeting in vivo. Our current data do not exclude
the possibility that FMRP may also be capable of binding other
methylated targets, such as nucleic acids.
This newly identified function of FMRP in the replication stress
response appears to be independent of the classical role of
FMRP in maintaining synaptic plasticity via translational regula-
tion. Instead, nuclear FMRPmay function in the DNA repair path-
ways through chromatin association. Our finding is consistent
with published observations, including the report that FMRP
interacts with poly(ADP-ribose) glycohydrolase (PARG) and
poly (ADP-ribose) polymerase (PARP), which are major modula-
tors of genomic stability (Gagne´ et al., 2005; Isabelle et al., 2010,
Ciccia and Elledge, 2010; Haince et al., 2007). The fact that the
DNA topoisomerase TOP3b is present in FMRP-containing
mRNPs, is involved in neuronal development and genomic
stability, and contributes to germ cell development suggests
yet another intriguing connection between FMRP and the DDR.
It is interesting to note that similar to FMRP, TOP3b is also
associated with XY bivalents during pachytene (Kwan et al.,
2003). We speculate that FMRP performs a docking function to
regulate the chromatin accessibility of DDR proteins. Although
the detailed molecular mechanisms of FMRP-dependent DDR
await further clarification, our data on the connection of FMRP
with chromatin in the DDR represent an important advance in
our understanding of FMRP function.
Importantly, DDR events such as gH2A.X induction and ATR/
BRCA1 signaling heavily influence meiosis, specifically cross-
over formation and synapsis (Turner et al., 2004, 2005). Defects
in synapsis can lead to chromosome nondisjunction, resulting in
impaired gamete development or the generation of aneuploid
gametes and developmental defects in the resulting embryo
(Handel and Schimenti, 2010). Our findings suggest that the–881, May 8, 2014 ª2014 Elsevier Inc. 877
Figure 7. Abnormal BRCA1 and ATR Loading and Synapsis Defects in Fmr1 KO Spermatocytes
(A) Sample images of BRCA1 staining in pachytene spermatocytes in WT and KO animals. In WT, BRCA1 staining is continuous and restricted to the sex
chromosomes (arrowhead). In KO, it is discontinuous and frequently present on the autosomes. SYCP3 marks the chromosomes.
(B) Sample images of ATR staining in pachytene spermatocytes in WT and KO animals. In WT, ATR staining forms a cloud around the sex chromosomes
(arrowhead) and is absent from the autosomes. In KO, ATR staining is retained in puncta on the autosomes and sometimes coats a complete autosome (bottom
panels). SYCP3 marks the chromosomes.
(C) Percentage of cells that retained BRCA1 or ATR outside of the sex chromosomes in WT and KO spermatocytes. *p < 0.05; **p < 0.01, Fisher’s exact test.
(D) Costaining of lateral (SYCP3) and central (SYCP1) elements of the SC shows discontinuous SYCP1 staining in Fmr1 KO cells, indicating defective SC
formation.
(E and F) Methylated H3K79 helps to recruit FMRP to chromatin.
(E) Staining of FMRP in pachytene spermatocyte spreads from WT and Dot1L cKO mutants. Chromosome-associated FMRP signal is reduced in cKO cells,
especially near the X and Y chromosomes. SYCP3 marks the chromosomes.
(F) Quantitation of X- and Y-chromosome-associated FMRP foci. **p < 0.01, unpaired t test. Scale bars, 10 mm.
See also Figures S1C and S7C–S7E.
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rate of germline chromosomal instability among Fmr1 KO mice
or fragile X patients at sites outside the fragile X locus may be
elevated. This hypothesis is supported by a recent study that
described increased rates of DNA damage and apoptosis in
spermatocytes of Fmr1 KO mice (Tian et al., 2013). In addition,
low FMRP levels were correlated with spermatogenesis defects
in patients with maturation arrest (Tian et al., 2013). Thus, our
findings provide a potential molecular mechanism for the DNA
damage, apoptosis, and spermatogenesis defects observed in
mice and patients lacking FMRP.
Interestingly, in yeast Dot1 mutants, meiotic cells exhibit
increased levels of unrepaired DNA damage and proceed
through sporulation to produce mature spores with poor viability
(San-Segundo and Roeder, 2000). In mouse spermatocytes,
DOT1L chromatin loading and H3K79 methylation are dynami-
cally regulated during meiosis. In particular, H3K79me3 and
DOT1L protein accumulate at the sex chromosomes, and
H3K79me3 accumulates at centromeres during the pachytene
stage (Ontoso et al., 2014). Our finding that FMRP is depleted
at the sex chromosomes in Dot1L conditional mutants supports
an interaction between FMRP and methylated histones during
meiosis, and raises the possibility that H3K79 methylation may
be important for FMRP chromatin association in vivo. Interest-
ingly, the Tudor domain of Survival Motor Neuron protein
(SMN), which carries a methyl-lysine interacting surface similar
to that of the FMRP Agenet domain (Ramos et al., 2006), was
recently shown to interact with H3K79me1/2 in a DOT1L-depen-
dent manner (Sabra et al., 2013)
Macroorchidism is a hallmark of fragile X syndrome, but little is
known with respect to its etiology. Malformed spermatids have
been observed in both human fragile X patients and Fmr1 KO
mice, suggesting a defect in sperm development (Slegten-
horst-Eegdeman et al., 1998; Johannisson et al., 1987). Adult
male patients carrying the full fragile X repeat expansion produce
sperm that carry a contracted premutation but never the full
expansion (Reyniers et al., 1993), implying that sperms carrying
a full mutation are selected against at a premeiotic stage, allow-
ing only those with a contracted FMR1 repeat to reach maturity
(Ba¨chner et al., 1993; Malter et al., 1997). Our finding that sper-
matocytes lacking FMRP exhibit defects in chromosome syn-
apsis during meiotic prophase lends support to this model,
and suggests a mechanism for this effect.
The idea of a functional involvement of FMRP in the DDR is
especially appealing given recent evidence pointing to FMRP
as a prosurvival protein. The absence of FMRP promotes
apoptosis (Jeon et al., 2011) and telomere erosion in fragile X
patients, which is a major hallmark of genomic instability (Jen-
kins et al., 2008). In addition, fragile X patients have been
reported to display a lower incidence of cancer (Schultz-Peder-
sen et al., 2001), whereas an increase in FMRP levels promotes
tumor metastasis (Luca´ et al., 2013). Lastly, given that the loss of
FMRP function leads to a common form of intellectual disability
and autism, it is tempting to speculate that the role of FMRP in
the DDR might represent a novel, previously unappreciated
contributing factor in the development of fragile X syndrome.
Interestingly, a forward genetic screen in Drosophila identified
26 missense mutations in the N terminus of dFMRP that affect
axonal development (Reeve et al., 2005). Some of these muta-tions are localized to the dFMRP Agenet domain and are
predicted to impact the ability of dFMRP to bind chromatin. It
has been suggested that the Agenet domain may also play a
role in the translation-independent function of FMRP in synaptic
signaling (Deng et al., 2013). Therefore, it remains to be deter-
mined whether, in addition to its role in germ cell meiosis
reported here, this nuclear function of FMRP also affects
neuronal development, and whether the loss of FMRP has any
DDR-related consequences in patients with fragile X syndrome.
EXPERIMENTAL PROCEDURES
Native Nucleosome Binding Reactions
Reactions were performed in the presence of binding buffer (50 mM Tris
pH 7.5, 150 mM NaCl, 2 mMMgCl2, 0.1% Triton X-100) using 100 ng of gluta-
thione S-transferase (GST) fusion proteins and 5 mg of native nucleosomes
isolated from HeLa cells at +4C, and rotated for 2 hr before addition of gluta-
thione agarose beads (GE Healthcare). Beads were washed four times with
binding buffer. Three independent experiments were performed.
MLA Nucleosome Binding Reactions
Mononucleosomes were prepared as described previously (Lu et al., 2008).
The reactions were performed similarly to native nucleosome binding reac-
tions, but using 2 mg of MLA nucleosomes. Three independent experiments
were performed.
gH2A.X Induction Rescue Experiments
HeLa cells were transfected with FMRP small hairpin RNA (shRNA) or control
scramble shRNA. Scramble shRNA was cotransfected with empty backbone
vector (POZ-Flag-HA). FMRP shRNA was cotransfected with Flag-HA vector
alone or with rescue vectors expressing either wild-type or mutant forms of
FMRP (Flag-HA-FMRP, Flag-HA-T102Y, or Flag-HA-Y103L). At 3 days post-
transfection, cells were treated with DMSO or APH (0.5 mM) for 24 hr and
then lysed in SDS sample buffer. Samples were subjected to western blotting.
FMRPKOMEF rescue experiments were performed identically to HeLa rescue
experiments, except that rescue constructs were introduced into cells using
the pMSCV-Flag-HA viral system. Three independent experiments were
performed.
FMRP Chromatin Recruitment Experiments
Chromatin fractionation experiments were adopted fromMe´ndez and Stillman
(2000). Briefly, after 1 mMAPH treatment of MEFs for 24 hr, chromatin was iso-
lated by resuspending cells in buffer A (10 mM HEPES [pH 7.9], 10 mM KCl,
1.5 mM MgCl2, 1 mM dithiothreitol [DTT], 3 mM EDTA, 0.5% Triton X-100,
and protease inhibitor cocktail [Roche]) and nuclei were collected by low-
speed centrifugation (4 min, 1,300 3 g), washed once in buffer A, and lysed
in buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT, and protease inhibitor
cocktail [Roche]). Insoluble chromatin was collected by centrifugation
(4 min, 1,700 3 g), washed again in buffer B, and centrifuged again. The final
chromatin pellet was resuspended in Laemmli buffer, sonicated, and boiled for
15 min. Total protein lysate for determination of total protein levels was
aliquoted from cells still resuspended in buffer A. All procedures were per-
formed at +4C. Three independent experiments were performed.
Immunofluorescence Experiments
MEFswere treated with 10 ng/ml of LPB for 24 hr in the presence or absence of
0.5 mM APH. Cells were then fixed with ice-cold methanol, stained with the
antibodies of interest, and mounted using DAPI mounting medium (Vecta-
shield). MEFs were counted according to the number of nuclear FMRP foci
or large CMC-associated FMRP domains (CMCs) after LPB+DMSO or
LPB+APH treatment (24 hr). When Bethyl anti-BRCA1 and anti-RPA32 rabbit
antibodies were used for staining, cells were extracted with CSK buffer
(10 mM HEPES pH 7.4, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl2, 0.5%
Triton X-100) for 30 min at room temperature and then fixed in 4%Cell 157, 869–881, May 8, 2014 ª2014 Elsevier Inc. 879
paraformaldehyde (PFA) for 10 min, followed by washes in PBS and immuno-
staining. A total of 100 cells were counted in three independent experiments.
Preparation of Meiotic Chromosome Spreads
Male Fmr1KO/Y and +/Y or Dot1L D/D and Dot1Lfl/+ littermates were sacrificed
at 7 weeks of age. At least two individuals of each genotypewere used for each
experiment. The spread preparation protocol was modified from Peters et al.
(1997). Testes were immersed in Dulbecco’s modified Eagle’s medium and the
tunicae were removed. The separated tubule suspension was spun for 8min at
1,000 3 g, and cells were resuspended in 1 ml hypo-buffer (30 mM Tris-HCl
pH 8.2, 50 mM sucrose pH 8.2, 17 mM sodium citrate) and incubated for
7 min at room temperature. The cell suspension was split into five tubes and
spun for 8 min at 1,000 rpm. It was then resuspended in 170 ml 0.1 M sucrose
and dropped onto the slides, and allowed to spread for 2–3 hr. Slideswere pre-
pared with 1% PFA with 0.1% Triton X-100, pH 9.2. For staining, slides were
blocked in 3% BSA for 1 hr, incubated with primary antibody in 1% BSA over-
night at 4C, and then incubated with secondary antibody in 1%BSA for 1 hr at
room temperature. Imaging was performed on a DeltaVision Elite deconvolu-
tion imaging system (Applied Precision) at 603 or 1003magnification. Stacks
were compressed and analyzed using ImageJ software. The morphology of
SYCP3-stained chromosomes was used to determine the stage of prophase.
For further details regarding the materials and methods used in this work,
see Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cell.2014.03.040.
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